CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		11 Months Ended		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2024	Dec. 31, 2023		Feb. 08, 2022	[1]
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations		$ 12,979	[1],[2]	$ 70,380	$ 34,722
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments		(93,554)	[1]	(879,719)	(206,879)
Proceeds from principal repayments and sales of investments		38,221	[1]	201,591	47,485
Payment-in-kind interest		(1,275)	[1]	(4,427)	(2,333)
Amortization of premium/accretion of discount, net		(506)	[1]	(1,259)	(820)
Net realized (gain) loss on investments		347	[1]	(766)	(768)
Net change in unrealized (appreciation) depreciation on investments		3,480	[1]	1,940	652
Amortization of deferred financing costs		14	[1]	623	174
Amortization of offering costs		0	[1]	7	0
NCPCF Acquisition, net of cash acquired	[3]	0	[1]	(206,529)	0
Changes in operating assets and liabilities:
Due from affiliate for expense support		(2,215)	[1]	(656)	(753)
Receivable for investments sold		(196)	[1]	(13,189)	35
Interest receivable		(4,282)	[1]	378	(1,330)
Prepaid expenses		(29)	[1]	(3)	(12)
Payable for investments purchased		0	[1]	11,679	338
Interest payable		533	[1]	11,613	97
Management fee payable		0	[1]	745	0
Due to affiliate for expense support		2,215	[1]	656	753
Board of Trustees' fees payable		128	[1]	0	0
Accounts payable and accrued expenses		985	[1]	(162)	777
Net cash provided by (used in) operating activities		(43,155)	[1]	(807,098)	(127,862)
Cash flows from financing activities:
Proceeds from issuance of common shares		1	[1]	449,958	92,850
Repurchased shares, net of early repurchase deduction		0	[1]	(980)	0
Proceeds from secured borrowings		162,500	[1]	1,012,100	135,250
Repayments of secured borrowings		(7,500)	[1]	(549,850)	(124,500)
Repayments of Note		(32,731)	[1]	0	0
Distributions paid		(13,070)	[1]	(42,298)	(32,568)
Payments of deferred financing costs		(260)	[1]	(3,567)	(276)
Net cash provided by (used in) financing activities		108,940	[1]	865,363	70,756
Net increase (decrease) in cash and cash equivalents		65,785	[1]	58,265	(57,106)
Cash and cash equivalents, beginning of period				8,679	65,785	[1]
Cash and cash equivalents, end of period		65,785	[1]	66,944	8,679
Supplemental disclosure of cash flow information:
Cash paid during the period for interest		3,702	[1]	7,033	10,482
Financing costs paid through expense support		462	[1]	0	2
Amortization of deferred financing costs paid through expense support		60	[1]	0	0
Cash paid during the period for excise taxes		0	[1]	33	2
Investments acquired through NCPCF Acquisition		0	[1]	486,933	0
Debt assumed from NCPCF Acquisition		0	[1]	281,500	0
Supplemental disclosure of non-cash flow information:
Purchases of investments		(296,231)	[1]	0	0
Issuance of common shares, net		263,500	[1]	0	0
Reinvestment of shareholder distributions		0	[1]	21,115	847
Payable for share repurchases		0	[1]	2,005	0
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Cash		65,785		3,721	1,089
Cash Equivalents		0		63,223	7,590
Total cash and cash equivalents and restricted cash shown on the Consolidated Statements of Cash Flows		$ 65,785	[1]	$ 66,944	$ 8,679		$ 0

[1] For the period February 8, 2022 (inception) through December 31, 2022.

[2] For the period February 8, 2022 (inception) through December 31, 2022

[3] On December 11, 2024, in connection with the Fund’s acquisition of substantially all of Nuveen Churchill Private Credit Fund’s assets and liabilities, the Fund acquired total assets of $506,973, inclusive of $486,933 of investments, $14,448 of cash and cash equivalents and $5,592 of other assets, net of $285,996 of assumed liabilities, inclusive of $281,500 outstanding debt obligations. See Note 11 “NCPCF Acquisition” for more information.